(*) USA Approval Date: 2020. 04.06
>recombinant Coagulation Factor VII
Company
Company Licensee CA & USA
Generic Name: Eptacog Beta
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2022. 02.01
RTM USA
RTM USA Web-Site